Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation
1 other identifier
interventional
16
1 country
1
Brief Summary
Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2021
CompletedStudy Start
First participant enrolled
March 15, 2021
CompletedFirst Posted
Study publicly available on registry
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2022
CompletedFebruary 13, 2023
February 1, 2023
1.5 years
March 15, 2021
February 9, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Diaphragm muscle activation
The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia).
10 minutes
Sternocleidomastoid muscle activation
The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGSCM).
10 minutes
Secondary Outcomes (3)
The mean median frequency of diaphragm and sternocleidomastoid muscle
10 minutes
Functional exercise capacity
Considering time of test and recovery, it will be expected to take totally 10 minutes.
Quality of life evaluation
10 minutes
Study Arms (2)
Inspiratory muscle training combined pulmonary rehabilitation
EXPERIMENTALSham inspiratory muscle training combined pulmonary rehabilitation
SHAM COMPARATORInterventions
Intensity of inspiratory muscle training will be set at 30% of maximal inspiratory pressure. Subjects in intervention experimental group will perform 15 breaths per set, 6 sets per day on daily basis. The intervention will be last for 8 weeks.
Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.
Eligibility Criteria
You may qualify if:
- age \> 20 years old
- diagnosed as exacerbation of COPD
- maximal inspiratory pressure (MIP) \< 80 cmH2O
You may not qualify if:
- any clinical diagnosis that will influence the measurement, including any history of neuromyopathy
- angina, acute myocardial infarction in the previous one month
- pregnancy
- participated in inspiratory muscle training program in the previous three months
- any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) \< 24, that will disturb the communication and cooperation of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School and Graduate Institute of Physical Therapy of National Taiwan University
Taipei, Zhongzheng Dist, 100, Taiwan
Related Publications (1)
Huang WY, Lee CT, Chien JY, Hsu M, Wang LY. Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease Exacerbations: A Randomized Controlled Trial. Am J Phys Med Rehabil. 2025 May 1;104(5):458-464. doi: 10.1097/PHM.0000000000002654. Epub 2024 Nov 11.
PMID: 39774113DERIVED
Study Officials
- STUDY CHAIR
Li-Ying Wang, PhD
National Taiwan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2021
First Posted
March 17, 2021
Study Start
March 15, 2021
Primary Completion
September 16, 2022
Study Completion
September 16, 2022
Last Updated
February 13, 2023
Record last verified: 2023-02